|
Disclosures: Royalties or Patent Beneficiary-Takeda Pharmaceutical (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Allovir|Stocks or stock options, excluding diversified mutual funds-Marker Therapeutics - 04/14/2022
|